By David Li, bostonese.com
Boston-Cambridge area has long been the hub for pharmaceutical research. On April 7, Boston BioForum 2012 was held at MIT Faculty Club. The big conference hall was packed with 4 sessions, 2 panel discussions, 25 speakers, and more than 400 attendees. The day-long conference was hosted by Chinese-American BioMedical Association (CABA). In its five year history, CABA’s contribution to advancing biomedical research and bridging US and China in this field was well recognized by many speakers and attendees at Boston BioForum 2012.
Panel discussion.
| The 2012 Excellence in Innovation Award was presented to Novartis, Idenix Pharmaceuticals and Bristol-Myers Squibb to recognize their contribution in the field of HBV drug development to help Hepatitis B patients. Hepatitis B is a major health issue in many developing countries, including China. The Leadership in Community Service award went to Pfizer, as it has provided continuous support to the biomedical and life science community, including organizations like CABA. |
An international award Advocate Excellence for Chinese Biomedical Enterprise was presented to Dr. Yan Li, director in chief, Wuhan SFDA, China to recognize her vision, leadership and significant contributions to the exchange between China and US in the field of food and drug regulatory affairs and impact in the SFDA policy making in China to promote public health. Four members of Wuhan SFDA enrolled in CABA’s training program in Lexington, MA last summer.
| In accord with its theme of “meeting the challenges through innovation”, Boston BioForum 2012 handled out the Innovator of the Year award to Dr. Chiang J Li to recognize his outstanding contributions and achievements in the discovery and development of first-in-class anti-cancer therapeutics to help patients with hard-to-treat cancers. Dr. Li returned the favor, and delivered a well-anticipated talk in the evening session, titled Building an Innovative Biotech: Lesson and Secrets in the evening session to put a fitting end to Boston BioForum 2012. |